Photodynamic therapy: a new antimicrobial approach to infectious disease?
- PMID: 15122361
- PMCID: PMC3071049
- DOI: 10.1039/b311900a
Photodynamic therapy: a new antimicrobial approach to infectious disease?
Abstract
Photodynamic therapy (PDT) employs a non-toxic dye, termed a photosensitizer (PS), and low intensity visible light which, in the presence of oxygen, combine to produce cytotoxic species. PDT has the advantage of dual selectivity, in that the PS can be targeted to its destination cell or tissue and, in addition, the illumination can be spatially directed to the lesion. PDT has previously been used to kill pathogenic microorganisms in vitro, but its use to treat infections in animal models or patients has not, as yet, been much developed. It is known that Gram-(-) bacteria are resistant to PDT with many commonly used PS that will readily lead to phototoxicity in Gram-(+) species, and that PS bearing a cationic charge or the use of agents that increase the permeability of the outer membrane will increase the efficacy of killing Gram-(-) organisms. All the available evidence suggests that multi-antibiotic resistant strains are as easily killed by PDT as naive strains, and that bacteria will not readily develop resistance to PDT. Treatment of localized infections with PDT requires selectivity of the PS for microbes over host cells, delivery of the PS into the infected area and the ability to effectively illuminate the lesion. Recently, there have been reports of PDT used to treat infections in selected animal models and some clinical trials: mainly for viral lesions, but also for acne, gastric infection by Helicobacter pylori and brain abcesses. Possible future clinical applications include infections in wounds and burns, rapidly spreading and intractable soft-tissue infections and abscesses, infections in body cavities such as the mouth, ear, nasal sinus, bladder and stomach, and surface infections of the cornea and skin.
Figures





Similar articles
-
Photodynamic therapy targeted to pathogens.Int J Immunopathol Pharmacol. 2004 Sep-Dec;17(3):245-54. doi: 10.1177/039463200401700304. Int J Immunopathol Pharmacol. 2004. PMID: 15461858 Free PMC article. Review.
-
Photodynamic therapy for localized infections--state of the art.Photodiagnosis Photodyn Ther. 2009 Sep-Dec;6(3-4):170-88. doi: 10.1016/j.pdpdt.2009.10.008. Photodiagnosis Photodyn Ther. 2009. PMID: 19932449 Free PMC article. Review.
-
Photodynamic therapy for infections: clinical applications.Lasers Surg Med. 2011 Sep;43(7):755-67. doi: 10.1002/lsm.21080. Lasers Surg Med. 2011. PMID: 22057503 Free PMC article. Review.
-
Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria.J Photochem Photobiol B. 2005 Oct 3;81(1):15-25. doi: 10.1016/j.jphotobiol.2005.05.007. J Photochem Photobiol B. 2005. PMID: 16040251 Free PMC article.
-
Antibacterial photodynamic therapy in dermatology.Photochem Photobiol Sci. 2004 Oct;3(10):907-17. doi: 10.1039/b407622b. Epub 2004 Sep 16. Photochem Photobiol Sci. 2004. PMID: 15480480 Review.
Cited by
-
Photochemotherapeutic strategy against Acanthamoeba infections.Antimicrob Agents Chemother. 2015;59(6):3031-41. doi: 10.1128/AAC.05126-14. Epub 2015 Mar 9. Antimicrob Agents Chemother. 2015. PMID: 25753633 Free PMC article.
-
Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistant Staphylococcus aureus and improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/Cl in infected mouse skin abrasion.J Biophotonics. 2013 Sep;6(9):733-42. doi: 10.1002/jbio.201200121. Epub 2012 Sep 14. J Biophotonics. 2013. PMID: 22987338 Free PMC article.
-
Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria.Lasers Surg Med. 2012 Aug;44(6):490-9. doi: 10.1002/lsm.22045. Epub 2012 Jul 3. Lasers Surg Med. 2012. PMID: 22760848 Free PMC article.
-
Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans.PLoS One. 2013;8(1):e54387. doi: 10.1371/journal.pone.0054387. Epub 2013 Jan 18. PLoS One. 2013. PMID: 23349872 Free PMC article.
-
Photodynamic antimicrobial chemotherapy in mice with Pseudomonas aeruginosa-infected wounds.PLoS One. 2020 Sep 2;15(9):e0237851. doi: 10.1371/journal.pone.0237851. eCollection 2020. PLoS One. 2020. PMID: 32877414 Free PMC article.
References
-
- Hamblin MR, Newman EL. On the mechanism of the tumour-localising effect in photodynamic therapy. J. Photochem. Photobiol., B. 1994;23:3–8. - PubMed
-
- Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol., B. 1997;39:1–18. - PubMed
-
- Athar M, Mukhtar H, Bickers DR. Differential role of reactive oxygen intermediates in photofrin-I- and photofrin-II-mediated photoenhancement of lipid peroxidation in epidermal microsomal membranes. J. Invest. Dermatol. 1988;90:652–657. - PubMed
-
- Redmond RW, Gamlin JN. A compilation of singlet oxygen yields from biologically relevant molecules. Photochem. Photobiol. 1999;70:391–475. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical